Literature DB >> 9583774

Epileptic seizure associated with intracerebroventricular and intrathecal morphine bolus.

M F Kronenberg1, I Laimer, C Rifici, L Saltuari, P Bramanti, U Moriggl, B Norer, A Kofler.   

Abstract

We report on two patients with morphine-related seizures associated with either intrathecal or intracerebroventricular administration. Both patients had a history of malignant tumor and both experienced the seizures following bolus application of morphine, while even higher dosages were well tolerated when continuously infused. Seizures occurred without signs of intoxication. Initiation of intrathecal morphine therapy and bolus application should be performed carefully and only when constant monitoring is provided for at least 12 h. Animal data and possible mechanisms for morphine-related seizures are discussed.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9583774     DOI: 10.1016/s0304-3959(97)00173-5

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  4 in total

Review 1.  Intracerebroventricular opioids for intractable pain.

Authors:  Robert B Raffa; Joseph V Pergolizzi
Journal:  Br J Clin Pharmacol       Date:  2012-07       Impact factor: 4.335

Review 2.  Morphine-3-Glucuronide, Physiology and Behavior.

Authors:  Florian Gabel; Volodya Hovhannisyan; Abdel-Karim Berkati; Yannick Goumon
Journal:  Front Mol Neurosci       Date:  2022-05-12       Impact factor: 6.261

3.  Endomorphin-2 Decreases Excitatory Synaptic Transmission in the Spinal Ventral Horn of the Rat.

Authors:  Zhen-Yu Wu; Ya-Cheng Lu; Ban Feng; Ying-Biao Chen; Yang Bai; Ting Zhang; Hua Zhang; Tao Chen; Yu-Ling Dong; Hui Li; Yun-Qing Li
Journal:  Front Neural Circuits       Date:  2017-08-08       Impact factor: 3.492

Review 4.  Serious Adverse Events after a Single Shot of Intrathecal Morphine: A Case Series and Systematic Review.

Authors:  Mark V Koning; Elmer Reussien; Beatrijs A N Vermeulen; Svenja Zonneveld; Elsbeth M Westerman; Jurgen C de Graaff; Bernard M Houweling
Journal:  Pain Res Manag       Date:  2022-03-10       Impact factor: 3.037

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.